OverviewChartNewsTraderScreen

Soc. Generale Discount Zert Novo-.../  DE000SW7HE76  /

EUWAX
20/06/2024  10:04:57 Chg.+0.42 Bid22:00:36 Ask22:00:36 Underlying Strike price Expiration date Option type
128.00EUR +0.33% -
Bid Size: -		 -
Ask Size: -		 - - DKK 27/09/2024 Call
GlobeNewswire 18/06 Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesit...
GlobeNewswire 18/06 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 17/06 Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Share...
TeleTrader 15/06 Novo Nordisk CEO to voluntarily testify before US committee
GlobeNewswire 14/06 Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs
GlobeNewswire 13/06 Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Chil...
GlobeNewswire 13/06 Biosplice Announces Collaboration with Novo Nordisk in Diabetes
GlobeNewswire 11/06 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
GlobeNewswire 10/06 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire 10/06 Veru to Present at the American Diabetes Association's 84th Scientific Sessions
GlobeNewswire 03/06 Aeterna Zentaris and Ceapro Complete Merger Transaction
GlobeNewswire 03/06 Aeterna Zentaris and Ceapro Complete Merger Transaction
GlobeNewswire 31/05 Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia...
GlobeNewswire 30/05 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 22/05 Veru to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 15/05 Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Cl...
GlobeNewswire 15/05 Aeterna Zentaris Reports First Quarter 2024 Financial Results
GlobeNewswire 14/05 Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Sci...
GlobeNewswire 09/05 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 07/05 Vect-Horus to Take Part in a Roundtable Discussion at Viva Technology Conference
TeleTrader 25/04 Europe opens mostly down after corporate earnings
GlobeNewswire 22/04 Vect-Horus Publication in Pharmaceutics Outlines How Vectors Can Improve Delivery of Therapeutics to...
GlobeNewswire 22/04 SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into cli...
GlobeNewswire 22/04 SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into cli...
GlobeNewswire 11/04 Robbins LLP is Investigating the Acquisition of Catalent, Inc. (CTLT) by Novo Holdings